Mallinckrodt and Novoteris have been given a green light by Health Canada to start a pilot study of an inhaled formulation of nitric oxide (NO) as a possible treatment for coronavirus.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,